HTA46 Outcomes of Benefit Assessments of Orphan Drugs Without Orphan Designation in Germany
Autor: | Frick, L, Qiu, Z, Schönermark, M |
---|---|
Zdroj: | In Value in Health December 2022 25(12) Supplement:S305-S305 |
Databáze: | ScienceDirect |
Externí odkaz: |
Autor: | Frick, L, Qiu, Z, Schönermark, M |
---|---|
Zdroj: | In Value in Health December 2022 25(12) Supplement:S305-S305 |
Databáze: | ScienceDirect |
Externí odkaz: |